Group items tagged

Reports & Insights freshly released a new report entitled as "Digital Therapeutics Market: Opportunity Analysis and Future Assessment 2022-2030", in which the base year is considered for the study is 2021, estimated year is 2022, and the forecasted year is considered 2023-2030. The global Digital Therapeutics Market in 2022 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ $ 22.9 Bn by 2030 with a significant CAGR of 25.8%. The report promises to offer its clients with an absolute across-the-board, premium quality primary data about the market prospects and in-depth knowledge of the trends prevailing in the market. The report further aims to provide a quantitative and qualitative synopsis of the theoretical framework and rational approach of the market expatiate using certified research methodologies and proficient expertise. The global digital therapeutics market in 2020 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ 22.9 Bn by 2028 with a significant CAGR of 25.8%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1123 Digital Therapeutics Introduction The digital Therapeutics market includes a couple of segments such as application and end-use. The application segment further divided into six other categories such as diabetes, obesity, CVD, CNS, respiratory, and others. The end-user segment is further divided into patients, caregivers, employers, payers, and pharmaceutical companies. Furthermore, the study includes market estimation, market forecast, and market information for six geographical regions around the globe. In 2016, in the U.S. diabetes is the seventh major cause of death, which affects around 10% of the U.S. population that is around 30.0 million and around  95% of diabetic patients have type 2 diabetes that is significantly associated with behavioral factors such as heavy calorie intake and less physical activity. Digital Therapeutics Market Dynamics

The leading analysts and researchers at Reports and Insights compiled and outlined the assessment of the influence of recommendations on market operations and exercises. The research comprises data driven by the market's historical and present circumstances, as well as other elements impacting the market's development process. It comprises the leading-age and up-to-date information on the global Remote Patient Monitoring Devices Market outlook. The evaluation goes into information about revenue forecasts, volume, demand, growth, share, kinds, applications, and sales, among other things. The research analyzes a range of critical restrictions, comprising manufacturing capacity, item pricing, profit and loss figures, and distribution approaches.  The remote patient monitoring devices market is estimated to reach at a value of US$ 25.1 Bn by the end of 2022 and expected to reach at a value of US$ 93.8 Bn by 2030 with a significant CAGR of 17.9%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/7158 Remote Patient Monitoring Devices Introduction Remote patient monitoring (RPM) can be perceived as a healthcare delivery approach that employs technology to keep track of patient health outside of a conventional clinical atmosphere. RPM alludes to the specialized technology employed to electronically transfer information between patients and practitioners, and it is just one delivery system within the comprehensive telemedicine industry. Some of the few examples of remote health monitoring devices comprise uninterrupted glucose monitors that alert diabetes patients to take their insulin, whilst enabling their medical practitioner to check upon the disease, digital blood pressure monitors that allow patients to distantly send physicians their blood oxygen levels and blood pressure. Remote patient monitoring devices strike digital technology in order to transmit communications between providers and patients. Patients keep a chec

The recently published report titled, "Human Insulin Market: Opportunity Analysis and Future Assessment 2022-2030" in the database of the Reports and Insights be of assistance to a paradigm solution for clearer and greater understanding of the market. It is beneficial in determining the size of the market for particular products. These leading players functioning in this market are in rigorous competition in terms of innovation, technology, product pricing and product development. Moreover, the market study helps in establishing sales prophecies for its products and therefore, creating symmetrical adjustment between demand and supply of its products.  The human insulin market is estimated to reach at a value of 22.6 Bn by the end of 2022 and expected to reach at a value of US$ 30 Bn by 2030 with a significant CAGR of 3.6%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1394 Human Insulin Introduction Human insulin can be perceived as a synthetic insulin which is laboratory-grown to simulate the insulin actually present in human bodies. Human insulin was developed between the 1960s and 1970s and finally approved for pharmaceutical use in 1982. Earlier when human insulin was not developed, animal insulin, basically a purified form of pork (porcine) insulin, was utilized. Mjaorly, human insulin is used for controlling blood sugar in people who are suffering from type 1 diabetes (medical condition in which the human body does not form insulin and thus incapable to control the amount of sugar in the blood) or in people who are going through type 2 diabetes (medical condition in which the blood sugar of the patient's body is too high as the body does not form or utilize insulin in a usual manner) that cannot be regulated with oral medications only. Notably, the human insulin is successfully able to replace the insulin originally present or produced in the human body. The human insulin as it is injected in the patientâ

The key objective of the newly published report by Reports & Insights termed as "Disposable Medical Sensors Market: Opportunity Analysis and Future Assessment 2022-2030", is to offer its clients with an absolute all-embracing, superior quality primary data about the market potential and profound knowledge of the trends prevailing in the market. Reports & Insights provides the in-depth knowledge of the market developed by the acknowledged market expertise using verified research methodologies and proven analytical approaches. For the interest and intrigue of the readers, the report comes across at the outcome with a strong focus on the thorough outlining of the key players of the global Disposable Medical Sensors market. The disposable medical sensors market is estimated to reach at a value of US 9.3 Bn by the end of 2022 and expected to reach at a value of US$ 20 Bn by 2030 with a significant CAGR of 10.1%. Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/6541 Disposable Medical Sensors Introduction The disposable medical sensors are easy-to-use and low-cost health sensing devices designed for quick single-point or short-term evaluations. Disposable medical sensors majorly serve its utility in the prophylaxis, diagnosis, treatment, and supervision of patients. For instance, a disposable blood pressure sensor is employed in the course of surgery for constantly observing patients' blood pressure. These blood pressure measuring sensors are attached to a monitor on which patients' critical details can be observed. The disposable medical sensors also find application in the intensive-care units however they are renewed regularly every 24 hours. Disposable Medical Sensors Market Dynamics The invariably advancing medical science and healthcare industry in the present day and age is the major reason for the yield of such advanced disposable medical sensors, which holds an essential role in the basic monitoring of the

The report is titled as 'Drug-Device Combination Products Market: Opportunity Analysis and Future Assessment 2022-2030'. An overview of conceptual frameworks, analytical approaches of the Drug-Device Combination Products market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.

Reports & Insights freshly released a new report entitled as "Self-Testing Market: Opportunity Analysis and Future Assessment 2022-2030", in which the base year is considered for the study is 2021, estimated year is 2022, and the forecasted year is considered 2022-2030. The global Self-Testing Market in 2022 is estimated for more than US$ 20,465.0 Mn and expected to reach a value of US$ 38,495.3 Mn by 2030 with a significant CAGR of 8.2%. The report promises to offer its clients with an absolute across-the-board, premium quality primary data about the market prospects and in-depth knowledge of the trends prevailing in the market. The report further aims to provide a quantitative and qualitative synopsis of the theoretical framework and rational approach of the market expatiate using certified research methodologies and proficient expertise. The self-testing market is estimated to reach at a value of US$ 20,465.0 Mn by the end of 2022 and expected to reach at a value of US$ 38,495.3 Mn by 2030 with a significant CAGR of 8.2% Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/6752 Self-Testing Introduction Over the past few years, the surge of consumer fascination towards self-testing technologies has raucously reclined on the increased repute of direct-to-home testing kits and strips. Self-testing is laying the ground for new methods to diagnose, monitor, and treat people and their conditions. It is significant to observe that following the late 2000, a wide range of self-testing kits have been employed for diagnosing various conditions, especially cancer-associated such as fecal occult blood and PSA, chronic ailments including diabetes and urinary tract infections. A self-testing basically means a test that can be carried out at home on one's own in order to diagnose or determine various health issues. In addition, self-tests serve its utility as one of the several risk-downsizing measures that safeguards individ

Global Diabetes Devices Market Size & Share - Industry Report, 2025

"The global angiography equipment market size is expected to reach USD 16.2 billion by 2026. The market is expected to witness an exponential CAGR of 6.5% over the forecast period due to growing geriatric population, increasing prevalence of Cardiovascular Diseases (CVDs) with associated risk factors, technological advancements, and investments in the health tech sector. According to the World Health Organization (WHO) report, CVD is one of the leading causes of death in countries, such as U.S. and U.K. ​ Coronary Artery Disease (CAD) is the most prevalent form of CVD. Through Global Hearts Initiative, the WHO is supporting governments in controlling cardiovascular risk factors, such as hypertension and diabetes. All these factors are projected to boost the market expansion over the forecast period. Rapid development of the diagnostic imaging modalities providing better visualization and assessment of CVD is also likely to drive the angiography devices market in the years to come. Geographically, North America held the largest market share in 2018 and is expected to maintain its position during the forecast period. Countries, such as Brazil and China, export the medical devices from U.S. owing to the high standard of quality. Due to favorable government regulations in developing countries, such as Japan and China, the Asia Pacific region is projected to expand at a healthy CAGR during the estimated period. For instance, reimbursement policy in Japan encourages the local manufacturers to provide advanced angiography diagnostic devices."

"The global fractional flow reserve market size is expected to reach USD 1,080.3 million by 2025, progressing at a CAGR of 10.5% during the forecast period. Widening base of cardiovascular diseases coupled with mounting cases of diabetes in developed as well as developing economies is escalating the growth of the market. Additionally, launch of novel devices in fractional flow reserve (FFR) market such as guidewires and monitoring systems are also anticipated to aid market growth. For instance, in October 2017, GE Healthcare and Medis, a Dutch based imaging software provider entered into a collaborative agreement in an attempt to increase clinical availability of image-based fractional flow reserve technology, offered by Medis. Moreover, consolidation activities, such as acquisition of St. Jude by Abbott in 2017 in order to increase its foothold in the cardiovascular devices market, is likely to keep the market highly competitive and thereby, augur well for the overall market."

Global diabetes care devices & drugs market is expected to reach USD 85,591.2 million by 2022, supported by a CAGR of 5.2% during the forecast period of 2017 to 2022.

"The global surgical stapling devices market size is anticipated to reach USD 8.02 billion by 2026, progressing at a CAGR of 8.23% during the forecast period. Application of surgical staplers has gradually evolved from invasive surgeries to minimally invasive surgeries. With introduction of advanced surgical staplers, difficulties associated with the use of conventional staplers have been addressed. ​ Obesity is increasing among adults as well as adolescents below 18 years of age due to sedentary lifestyles and unhealthy diet patterns in this age group. In case of eating habits, people are more inclined towards fast food rather than healthy food. Growing busy schedule and increasing stress are both causing people to consume packed and processed food. Severe cases of obesity cause other conditions, such as diabetes and cardiovascular conditions, resulting in many opting for bariatric surgery. According to the Canadian Institute for Health Information (CIHI) 2014 data, the number of bariatric surgeries has drastically increased from 1,600 in 2006-2007 to 6,000 in 2012-2013. This indicates high demand for these surgeries owing to increasing awareness about surgical options for weight loss."

"Smart insulin pens are devices that are used to administer insulin for the treatment of diabetes. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Smart Insulin Pens Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China)."